Blog
RSS FeedPosted by Michael Wonder on 24 Jan 2020
After years of campaigning, PHARMAC agrees to fund 'wonder drug' to treat kids with cystic fibrosis
24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund the long-campaigned for drug Kalydeco ...
Posted by Michael Wonder on 24 Jan 2020
PHARMAC seeking views on new cystic fibrosis medicine
24 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Vertex to fund ivacaftor (marketed as Kalydeco) ...
Posted by Michael Wonder on 23 Jan 2020
PHARMAC protest ride from Dunedin ends with conflict in Parliament
22 January 2020 - A couple’s tandem cycle ride from Dunedin to Wellington, to call for increased PHARMAC funding, has ...
Posted by Michael Wonder on 22 Jan 2020
Parents demanding PHARMAC funding boost unleash on politicians at Parliament steps
22 January 2020 - The parents of a daughter with cystic fibrosis have cycled 1300 km from Dunedin to Wellington ...
Posted by Michael Wonder on 21 Jan 2020
Mum says 'miracle' drug saved ill baby Kaan Hunter's life
21 January 2020 - A baby who was given only four months to live after being diagnosed with an extremely ...
Posted by Michael Wonder on 16 Jan 2020
Epilepsy deaths: level of risk in medication brand switch unclear, study says
17 January 2020 - Five deaths in people with epilepsy following a brand switch may be part of an under-represented level ...
Posted by Michael Wonder on 15 Jan 2020
Thousands to benefit as PHARMAC set to fund better diabetes drugs
15 January 2020 - Better diabetes drugs are set to be publicly funded - a breakthrough that will help keep ...
Posted by Michael Wonder on 15 Jan 2020
PHARMAC considering new medicines for type 2 diabetes mellitus
15 January 2020 - PHARMAC is seeking proposals from pharmaceutical suppliers for new medicines that could help New Zealanders living ...
Posted by Michael Wonder on 15 Jan 2020
Proposal to fund betamethasone dipropionate with calcipotriol (Enstilar) foam spray for psoriasis
15 January 2020 - PHARMAC is seeking feedback on a proposal to fund a new topical psoriasis medicine, betamethasone dipropionate ...
Posted by Michael Wonder on 15 Jan 2020
RFP - supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors
15 January 2020 - PHARMAC invites proposals for the supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors in ...
Posted by Michael Wonder on 14 Jan 2020
It's given me so much hope': PHARMAC announces breast cancer drug deal
15 January 2020 - Wiki Mulholland has watched friends die around her since her terminal breast cancer diagnosis 18 months ...
Posted by Michael Wonder on 14 Jan 2020
PHARMAC seeking views on new breast cancer medicine
15 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Pfizer to fund palbociclib (marketed as Ibrance) ...
Posted by Michael Wonder on 14 Jan 2020
Coffin drawn through Timaru draws attention to health care 'truth'
14 January 2020 - Camilla and Julian Cox cycled into Timaru on Monday pulling a coffin behind their tandem as ...
Posted by Michael Wonder on 13 Jan 2020
Myeloma NZ calls on PHARMAC to make good on access deal
14 January 2020 - Myeloma New Zealand is today calling on PHARMAC to make good on their proposal to widen ...
Posted by Michael Wonder on 12 Jan 2020
Atomoxetine – further delay in change of funded brand and open access
10 January 2020 - PHARMAC is advising all interested parties that there is a further delay in the listing of ...